Tiziana Life Sciences Aktie
WKN DE: A2PTNF / ISIN: US88875G1013
|
15.12.2025 14:20:34
|
Tiziana Life Sciences Rescinds Proposed Public Offering
(RTTNews) - Tiziana Life Sciences, Ltd (TLSA), a biotechnology company developing its lead development candidate, intranasal foralumab, Monday announced that it is withdrawing its proposed public offering of common shares due to market conditions.
In pre-market activity, TLSA shares were trading at $1.85, up 3.93% on the Nasdaq.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Tiziana Life Sciences PLC (spons. ADRs)mehr Nachrichten
| Keine Nachrichten verfügbar. |